Oral transmucosal fentanyl citrate: A novel analgesic agent for use in retinal photocoagulation

Retina

Volumn 29, Issue 10, 2009, Pages 1506-1512

  Hillier, Roxane J ^a,b   Aboud, Ahlam ^a   Thind, Gurvinder ^a   Clark, David I ^a  

^a UNIVERSITY HOSPITAL AINTREE   (United Kingdom)

^b MANCHESTER ROYAL EYE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL CITRATE; PLACEBO; FENTANYL; NARCOTIC ANALGESIC AGENT;

ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIZZINESS; DOUBLE BLIND PROCEDURE; DROWSINESS; FEMALE; HUMAN; LASER COAGULATION; LOZENGE; MALE; NAUSEA; PAIN ASSESSMENT; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RETINA; UNSPECIFIED SIDE EFFECT; VISUAL ANALOG SCALE; XEROSTOMIA; ANALGESIA; DIABETIC RETINOPATHY; MIDDLE AGED; MOUTH MUCOSA; ORAL DRUG ADMINISTRATION; POSTOPERATIVE PAIN; PROSPECTIVE STUDY; RETINA VEIN OCCLUSION;

ADMINISTRATION, ORAL; ADULT; AGED; ANALGESIA; ANALGESICS, OPIOID; CROSS-OVER STUDIES; DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; LASER COAGULATION; MALE; MIDDLE AGED; MOUTH MUCOSA; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PROSPECTIVE STUDIES; RETINAL VEIN OCCLUSION;

EID: 73349123502     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181ae70d4     Document Type: Article

References (24)

1. World Health Organization. Available at: www.who.int/ diabetes/facts/world-figures/en/. Accessed September 13, 2008.
2. Klein R, Klein BE, Moss SE, Cruikshanks KJ. The Wisconsin epidemiologic study of diabetic retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 1994;112:1217-1228.
3. Bunce C, Wormald R. Causes of blind certifications in England and Wales: April 1999-March 2000. Eye 2008;22:905-911.
4. Ryselkova A, Turczyn K, Makuc DM, et al.. Self-reported age-related eye diseases and visual impairment in the United States: results of the 2002 National Health Interview Survey. Am J Public Health 2008;98:454-461.
5. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings: DRS report number 8. Ophthalmology 1981;88:583-600.
6. Avery RL, Pearlman J, Pierimici DJ, et al.. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 2006;113:1695-1705.
7. Adamis AP, Altaweel M, Bressler NM, et al.. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals. Ophthalmology 2006;113:23-28.
8. Mohamed Q, Gillies MC, Wong TY. Management of diabetic retinopathy: a systematic review. JAMA 2007;298:902-916.
9. Weinberger D, Ron Y, Lichter H, et al.. Analgesic effect of topical sodium diclofenac 0.1% drops during retinal laser photocoagulation. Br J Ophthalmol 2000;84:135-137.
10. Cook HL, Newsom RSB, Mensah E, et al.. Entonox as an analgesic agent during panretinal photocoagulation. Br J Ophthalmol 2002;86:1107-1108.
11. Wu WC, Hsu KH, Chen TL, et al.. Interventions for relieving pain associated with panretinal photocoagulation: a prospective randomized trial. Eye 2006;20:712-719.
12. Vaideanu D, Taylor P, McAndrew P, et al.. Double masked randomised controlled trial to assess the effectiveness of paracetamol in reducing pain in panretinal photocoagulation. Br J Ophthalmol 2006;90:713-717.
13. Streisand JB, Busch MA, Egan TD, et al.. Dose proportionality and pharmacokinetics of oral transmucosal fentanyl citrate. Anesthesiology 1998;88:305-309.
14. Farrar JT, Cleary J, Rauck R, et al.. Oral transmucosal fentanyl citrate: randomized, double-blinded, placebo controlled trial for treatment of breakthrough pain in cancer patients. J Natl Cancer Inst 1998;90:611-616.
15. Gerwels JW, Bezzant JL, Le Maire L, et al.. Oral transmucosal fentanyl citrate premedication in patients undergoing outpatient dermatologic procedures. J Dermatol Surg Oncol 1994;20:823-826.
16. Sharar SR, Carrougher GJ, Selzer K, et al.. A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care. J Burn Care Rehabil 2002;23:27-31.
17. Landy SH. Oral transmucosal fentanyl citrate for the treatment of migraine headache pain in outpatients: a case series. Headache 2004;44:762-766.
18. Shaiova L, Wallenstein D. Outpatient management of sickle cell pain with chronic opioid pharmacotherapy. J Natl Med Assoc 2004;96:984-986.
19. Lancaster GA, Dodd S, Williamson PR. Design and analysis of pilot studies: recommendations for good practice. J Eval Clin Pract 2004;10:307-312.
20. Friedberg MA, Palmer RM. A new technique of local anesthesia for panretinal photocoagulation. Ophthalmic Surg 1991; 22:619-621.
21. Price DD, Finniss DG, Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 2008;59:565-590.
22. Farrar JT, Berlin JA, Strom BL. Clinically important changes in acute pain outcome measures: a validation study. J Pain Symptom Manage 2003;25:406-411.
23. Lind GH, Marcus MA, Mears ST, et al.. Oral transmucosal fentanyl citrate for analgesia and sedation in the emergency department. Ann Emerg Med 1991;20:1117-1120.
24. Aronoff GM, Brennan MJ, Pritchard DD, Ginsberg B. Evidence- based oral transmucosal fentanyl citrate (OTFC) dosing guidelines. Pain Medicine 2005;6:305-314.